ArticleAesthetic plastic surgery2026
Mapping the Impact of Glucagon-Like Peptide-1 Receptor Agonists on Aesthetic and Reconstructive Plastic Surgery: A Bibliometric Analysis of the 50 Most Cited Studies.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlucagon-like peptide-1 receptor agonists are increasingly prescribed for medical weight management and have rapidly gained relevance within plastic, aesthetic, and reconstructive surgery. Their widespread use has raised questions regarding perioperative safety, tissue quality, body contouring outcomes, and aesthetic aging, prompting a growing but fragmented body of literature.
methodsA bibliometric analysis was conducted using the Web of Science Core Collection to identify the 50 most cited publications addressing the intersection of glucagon-like peptide-1 receptor agonists and plastic, aesthetic, or reconstructive surgery. Bibliographic data were extracted and analyzed to evaluate publication trends, citation performance, contributing authors and institutions, journals, geographic distribution, and thematic structures. Keyword co-occurrence and network analyses were performed to identify dominant research domains and emerging topics.
resultsNearly all highly cited articles were published between 2023 and 2025, reflecting the recent and abrupt emergence of this field. The literature was geographically dominated by the USA and was distributed across a wide range of institutions and authors, without clear investigative hubs. Thematic analysis revealed three principal domains: aesthetic aging and facial soft-tissue changes, perioperative management and safety considerations, and body contouring following pharmacologically induced weight loss. Keyword clustering demonstrated an evolving shift from metabolic and bariatric contexts toward aesthetic and procedural decision-making.
conclusionsThe literature on glucagon-like peptide-1 receptor agonists in plastic surgery is rapidly expanding but remains conceptually immature and largely descriptive. This bibliometric analysis highlights current research priorities, influential contributions, and critical gaps, underscoring the need for prospective, outcome-driven studies to inform evidence-based surgical practice. LEVEL OF EVIDENCE V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42477152What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.